These studies were designed to determine the role of plateletactivating factor (PAF) 
Introduction
Cellular and humoral responses triggered by immune complexes are important in the pathogenesis of many inflammatory diseases. Formation of complement-fixing immune complexes in tissue can lead to a localized influx of neutrophils, which in turn release a diverse array of soluble mediators responsible for tissue damage (1) (2) (3) (4) . Considerable attention has been directed toward the proinflammatory roles of lysosomal granule constituents (e.g., proteases), oxidants (e.g., superox-glycero-3-phosphocholine)1 is elaborated by platelets, hepatocytes, endothelial cells, and by various inflammatory cells including monocytes, macrophages, neutrophils, and basophils (5) . Recently, mediator functions of PAF have been examined in the context of tissue-damaging acute inflammatory processes (6) (7) (8) (9) (10) (11) (12) . Concomitant in vitro studies have shown that, depending upon concentration, PAF can prime or directly activate granulocytes (I13-20). Vercellotti et al. (20) have recently shown that PAF priming of neutrophils leads to enhancement of superoxide generation, elastase release, aggregation, adhesive glycoprotein expression and lysis or detachment of endothelial cells.
In several animal species there is in vivo and in vitro evidence that PAF participates in immune complex-mediated processes. After addition of sensitizing antigen, PAF is produced by isolated IgE-sensitized mast cells (21) and basophils (22) . IgG aggregates or preformed immune complexes stimulate PAF production by isolated perfused rat livers (23) , peritoneal macrophages (24) , and isolated peripheral blood neutrophils and monocytes (25) (26) (27) (28) . PAF appears in the blood after induction of serum sickness (29) , systemic anaphylaxis (30) , and acute lung injury (31) in rabbits as well as after infusion of antigen into IgE-sensitized rabbits (32). Intravenous infusion of immune complexes or IgG aggregates into rabbits and mice results in the appearance of PAF in the blood and liver, respectively (26, 33) . Increased vascular permeability, systemic hypotension, intravascular lysosomal hydrolase secretion and neutropenia can be elicited by infusion of preformed immune complexes or IgG aggregates (33, 34) . These physiologic responses to immune complexes can be mimicked by infusion of PAF (26, (35) (36) (37) (38) . Additional support that responses to immune complex infusions may be mediated by PAF has been provided by studies in which both immune complex-induced PAF production and neutropenia are blocked by 6-methylprednisolone (26) and PG12 (25, 35) . PAF production and vascular permeability resulting from infusion of aggregated IgG into mice can be prevented by mononuclear phagocyte depletion suggesting that some immune complex-induced responses are mediated by PAF (33).
There is convincing in vivo and in vitro evidence that PAF can directly provoke rapid neutrophil-independent increases in microvascular permeability. Intradermal injection of PAF into rabbits results in a rapid, localized increase in vascular permeability independent of neutrophil, mast cell or platelet activation (6-1 1). Hellewell and Williams (12) have recently provided evidence that endogenous PAF production may contribute to changes in endothelial cells in postcapillary venules (39, 40) . In vitro studies with cultured human endothelial cells have shown that PAF stimulates Ca2" influx-efflux (41, 42) and associated cytoskeletal alterations that are associated with changes in cell shape and monolayer permeability to iodinated albumin (43) .
The present study addresses a potential autocrine-paracrine role for PAF in neutrophil-dependent immune complexinduced vascular injury. We present evidence that PAF, in addition to its putative role in neutrophil-independent early phase increases in vascular permeability, also contributes to immune complex induced vascular damage through interaction with PAF receptors on neutrophils.
Methods
Animals. Male Long-Evans specific pathogen-free rats (300-400 g; Charles River Breeding Laboratories, Inc., Wilmington, MA) were used for all studies. Intraperitoneal injections of ketamine (2.5-5.0 mg/100 g body wt) and sodium pentobarbital (5 mg/100 g body wt) were given for sedation and anesthesia.
Materials. L-652,731 (trans-2,5-bis; 3,4,5-trimethoxyphenyl tetrahydrofuran) and its cis-isomer, L-652,763 were from Dr. John C. Chabala, Merck, Sharp and Dohme, Rahway, NJ. Stock solutions of L-652,731 and L-652,763 (0.4 mg/ml sterile saline) were prepared daily in 1.0% dimethylsulfoxide (DMSO). Final concentrations of DMSO never exceeded 0.1% in any in vitro or in vivo experiments. Fluoresceinated F(ab')2 fragments (anti-BSA and anti-rabbit IgG) were purchased from Cooper Biomedical, Malvern, PA. Zymosan, FMLP, PAF, 2-deoxyribose, hypoxanthine, xanthine oxidase, thiobarbituric acid, and BSA (Cohn fraction V, essentially fatty acid free) were from Sigma Chemical Co., St. Louis, MO. l-0-[13H]hexadecyl-2-acetylglycero-3-phosphocholine (59 Ci/mmol) (3H-PAF) was purchased from New England Nuclear (Boston, MA). PAF activity was ascertained by measuring platelet release of serotonin (44) . Rat platelets were isolated as described by Henson (45) . Platelet-rich plasma was removed, pooled, and incubated at 37°C with 1 Ci/ml [3H]serotonin binoxalate (New England Nuclear) for 15 min. The platelets were sedimented at 2,500 g for 15 min and washed first in Tyrode's-gel without Ca2" and with EGTA and then in Tyrode's-gel without Ca2'. 2.5 X 108 [3H]serotonin-labeled platelets were finally incubated (37°C, 15 min) in duplicate with stimuli in a final volume of 0.4 ml Tyrode'sgel with Ca2+. The reaction was stopped by centrifuging at 12,000 g in a microfuge-12 (Beckman Instruments, Inc., Fullerton, CA) for 30 s. Serotonin release was measured by counting an aliquot of the supernatant fluid in a liquid scintillation counter. Serotonin release was expressed as a percentage of the total where total was determined after Triton X-100 Iysis of [3H]serotonin-labeled platelets. Incubation of platelets with increasing concentrations of PAF ( l0-7-_l0-M) resulted in dose-dependent serotonin release ranging from 6.0 to 95.9%. Stimulation of platelets with thrombin (1 U; Sigma) resulted in 71.0% serotonin release. Assay of platelet supernatants for lactate dehydrogenase (LDH) (46) revealed no evidence of platelet lysis by the commercial PAF preparation.
Buffers. Tyrode's-gel without Ca2+, Tyrode's-gel without Ca2' with EDTA, Tyrode's-gel with Ca(2+, Tyrode's-BSA without Ca2' and Tyrode's-BSA with Ca2+ were prepared as described by Lynch et al. (44) .
Peripheral blood neutrophils. Heparinized caval blood was collected from Long-Evans rats, pooled within the group, and the neutrophils isolated by centrifugation over a Histopague-1077 gradient after sedimentation of red blood cells with hydroxyethyl starch (6% Volex;
McGaw Laboratories, Glendale, CA) (44 (51, 52) . Immediately after intradermal injection of antibody, the rats received intravenous injections of BSA (10 mg in 1.0 ml saline), which also contained an aliquot (800,000 cpm) of radioactive indicator ('25I-labeled nonspecific rabbit IgG) for quantitation of dermal vascular injury. At specified time points, the rats were killed and tissue injury was quantitated by determination of the permeability index. As described previously, the permeability index in this model is the amount of radioactivity present within standard size full-thickness skin sites, compared with the radioactivity within 1.0 ml of caval blood (53) .
To examine the role of PAF-receptors on neutrophils in immune complex vasculitis, rats were depleted of neutrophils (< 200/mm3) with cyclophosphamide (75-100 mg/kg i.p., 4 Immunofluorescence studies were performed on cryostat sections of reversed dermal Arthus and reconstituted dermal vasculitis skin biopsies. Frozen sections were fixed in acetone (10 min), twice washed with PBS (5 min), and incubated (40 min; room temperature) with 1:50, 1:100, and 1:200 dilutions of fluoresceinated rabbit F(ab')2 directed against bovine serum albumin, fluoresceinated goat anti-rabbit IgG (heavy and light chain specific) F(ab')2 fragments, or saline. The sections were then washed with PBS (10 min X 3) and coverslipped with 0.1% p-phenylenediamine in glycerol. Sections were examined and photographed using a Zeiss Photomic III epifluorescent microscope.
Hydroxyl radical generation and measurement. Cell-free generation of hydroxyl radical was achieved by a hypoxanthine-xanthine oxidase system in the presence of added iron salt (54) . Hydroxyl radicals were detected by generation of thiobarbituric acid reactive chro-mogens resulting from deoxyribose degradation (55) . Briefly, reaction mixtures containing 200 p1 2-deoxy-D-ribose (5 mM), 200 pl buffer, pH 7.4 (0.024 M phosphate, 0.15 M NaCl), 200 Al hypoxanthine (2 mM), 50 pl FeCl3 (1 mM) and 20 A1 xanthine oxidase (51.7 U/ml) were incubated at 370C for 30 min. The buffer contained mannitol (10 mM), L-652,73 1 or 0.1% DMSO as indicated. After incubation, 0.5 ml of 1% (wt/vol) thiobarbituric acid (dissolved in 0.05 M NaOH) and 0.5 ml 2.8% (wt/vol) TCA was added. The mixtures were heated at 100IC for 10 min, cooled, and absorbances measured at 532 nm.
Results
Specific blockade of PAF-triggered rat neutrophil activation. Addition of increasing concentrations of PAF to rat peripheral blood neutrophils resulted in dose-dependent increases in 02 generation (Fig. 1) . However, when PAF over the same range of concentrations was added to neutrophils in the presence of the PAF receptor antagonist, L-652,731 (50 ptM), there was complete blockade of 0°production. In the presence of 5 pM L-652,73 1, the effect of the antagonist could be overridden by the highest concentration of PAF (l0-5 M).
The data shown in Fig In vitro priming ofrat neutrophils with PAF. To investigate the ability of PAF to "prime" neutrophils for superoxide responses, cells were incubated in the presence or absence of PAF at concentrations ranging from 10-" to 10-7 M. Neutrophils were incubated for 5 min at 37°C with buffer alone or 10 . with 50 pM L-652,731 and then washed. PAF or immune complexes were then added as indicated and 0-production measured. As shown in Fig. 3 , neutrophils preincubated only in buffer (without PAF) produced 3.8 nmol 01 following addition of immune complexes. Negative control cells generated 0.4±0.3 nmol 0-. Neutrophils that had been incubated in buffer alone and then exposed to increasing concentrations of PAF exhibited 0°responses at concentrations of PAF of 10-8 M and greater. Neutrophils exposed to very low concentrations (10-" to 10-9 M) of PAF produced markedly increased amounts of 01 following incubation with immune complexes. This "priming" effect was completely abolished when the neutrophils were preincubated with PAF in the presence of the PAF-receptor antagonist, L-652,731. Characterization of the "reconstituted" dermal vasculitis model. To develop a vasculitis model in which the role of PAF receptors on neutrophils could be examined, rats were depleted ofgranulocytes with cyclophosphamide and Arthus-like reactions were reconstituted by injection antibody intradermally together with aliquots of isolated peripheral blood neutrophils. Development of vascular injury, as defined by increased permeability, occurred in a dose-dependent manner similar in pattern to the classic reversed passive Arthus reaction (Fig. 6) . At equivalent antibody doses, the absolute degree of vascular damage achieved in reconstituted sites ranged from 35 to 43% of that observed in reversed passive Arthus sites. In contrast to the reversed passive Arthus reaction, in which there is a time-dependent increase in perivascular neutrophil accumulation at sites of immune complex deposition, reconstituted vasculitis sites exhibited relatively uniform histologic appearances at 0.5, 1, and 2 h (Fig. 7) . In the latter model, reconstituted neutrophils were distributed throughout the dermis and were less intimately associated with blood vessel walls (--) by injecting IgG anti-BSA with peripheral blood neutrophils (106) into the dermis of neutrophil-depleted rats. Antigen (BSA, 10 mg) was injected intravenously, rats were sacrificed after 2 h, and permeability indices determined as described previously. Some skin sites received only antibody (A) or only neutrophils (0 gg antibody). The data expressed represent means±SEM of three experiments in which three to four replicate sites were employed for each variable. Reversed passive Arthus reactions were induced using aliquots of the same antibody preparations and the reactions were terminated at 2 h. than in classic reversed passive Arthus reactions. The difference in neutrophil distribution in the reconstituted vasculitis model is perhaps best illustrated by the lack of neutrophils either within the vascular lumens or in the process of emigration through vessel walls. In both models, electron dense immune complex deposits were present within the neutrophils (Fig. 7) Since it has been suggested that formation ofhydroxyl radicals (H0) may be important in the pathogenesis of neutrophil-mediated tissue injury (56), we examined the effect of L-652,731 on H0 formation by measuring the appearance of thiobarbituric acid reactive products from deoxyribose (55) . As shown in Table I provided evidence that PAF participates in the pathogenesis of immune complex mediated dermal vascular injury through a mechanism triggered through PAF receptors on neutrophils.
The potential for augmentation of vascular injury as the result of PAF-triggered neutrophil priming is supported by this study. These observations support the concept that PAF is an important autocrine-paracrine inflammatory mediator and suggest a broader role for PAF than its capacity to provoke rapid, neutrophil-independent increases in vascular permeability (6-1 1). The major conclusions from this study are predicated on the specificity and high binding affinity of the recently synthesized PAF receptor antagonist, L-652,73 1, and the development of the reconstituted dermal vasculitis model. Hwang et al. provided extensive functional and binding analyses that strongly support the conclusion that L-652,731 acts exclusively as a competitive receptor antagonist to PAF (50) . In a comparative study, these investigators showed that L-652,731 is a more potent PAF antagonist than CV-3988, kadsurenone, and ginkolide B and that in competitive inhibition analyses of PAF-receptor sites on rabbit platelet membranes it has substantially greater affinity for PAF receptors. Our data indicate that L-652,731 selectively blocks PAF-triggered rat neutrophil activation (as measured by°2 generation and 3-glucuronidase secretion) and corroborate other studies which have shown that this antagonist is specific for the PAF receptor (12, 34, 50) . 0.482±0.08 § * Hydroxyl radical formation was assayed by formation of a thiobarbituric acid-reactive substance from deoxyribose (55) . Mean±SEM of three experiments performed in triplicate. * Addition of mannitol (10 mM), a nonspecific HO' scavenger, to xanthine oxidase/hypoxanthine markedly reduced appearance of reactive products; (P < 0.01; two-way analysis of variance).
§ No significant differences compared to values from xanthine oxidase/hypoxanthine above; (P > 0.1; two-way analysis of variance).
The reconstituted dermal vasculitis model affords the luxury of ex vivo neutrophil manipulation before introduction into the skin. While this model provides a useful investigative tool, several points should be emphasized. The degree ofinjury induced in the reconstituted dermal vasculitis model is substantially less than that achieved in the classic reversed dermal Arthus reaction. This is presumably due to the loose distribution of neutrophils around the outsides of vessels, less intimate contact between the neutrophils and vessel wall components, less efficient access to blood-borne mediators, and some loss of neutrophil viability upon introduction into the animal. These attributes of the reconstituted vasculitis are illustrated in Figs. 6 and 7. Despite these caveats, development of vascular injury is dependent on the formation of immune complexes and the presence of viable neutrophils. In the reconstituted dermal vasculitis model, maximum vascular leak occurs earlier than in the reversed passive Arthus reaction (Fig. 9 ). This may reflect the fact that in the former model, the entire complement of participating neutrophils is injected intradermally at time zero rather than being recruited from the vascular compartment over a period of several hours. It should be emphasized that blockade of neutrophil PAF receptors from the onset does not infer that PAF acts exclusively through neutrophil activation. In the reversed passive Arthus reaction it is likely that the importance of PAF-triggered neutrophil function is related to the concentration of neutrophils present at the site of inflam- Figure 7 . Transmission electron micrographs (TEMs) of reconstituted dermal vasculitis and classic reversed passive Arthus reaction 2 h after induction of injury. In the reversed passive Arthus reaction (A), neutrophils originating from the vascular space (t) have emigrated through the vessel wall and accumulated within the surrounding interstitium. There are numerous large, irregular electron dense immune complex deposits within the neutrophils (B). In the reconstituted vasculitis model (C), the injected neutrophils have distributed within the dermis. Although vascular injury is less pronounced in the reconstitution model than in the reversed Arthus, there is quantitative (Fig. 6) (Table II) conducted in our study revealed a relatively modest increase in vascular injury but nonetheless are supportive of the hypothesis that PAF-primed neutrophils can amplify tissue injury. A possible explanation for the less marked in vivo priming effect seen in our study hinges on the observation neutrophils damage blood vessels "from without" in the reconstitution model. One result of this model characteristic would be the lessened importance of direct neutrophilendothelial cell adhesive interactions. Among the effects of PAF-triggered neutrophil priming reported by Vercellotti et al. was increased granulocyte adhesion and surface adhesogen (CR3) expression (20). It is likely that the diminution of specific endothelial cell-neutrophil adhesive interactions would lessen the enhancement of vascular injury that can be achieved by PAF-primed neutrophils. Clearly, the in vivo system is complex and other factors doubtlessly influence the magnitude of vascular leak that occurs in immune complex vasculitis. The present study supports the premise that both direct neutrophil activation and neutrophil priming by PAF could potentially be operative in the pathogenesis of immune complex vasculitis. It is possible that the predominant PAF-induced effects on neutrophil function in evolving tissue injury vary depending on the local concentration of PAF and the stage at which the response is examined.
In evolving immune complex vasculitis the cellular sources of endogenous PAF are unknown. Kravis and Henson (59) demonstrated an early phase of neutrophil and complementindependent edema formation and platelet accumulation at skin sites in reversed passive Arthus reactions in rabbits. They suggested that PAF released from tissue mast cells by an IgEdependent mechanism may be responsible. PAF is also produced by neutrophils, endothelial cells, and platelets (5). Hellewell and Williams (12) have suggested that PAF is formed in close proximity to microvascular endothelial cells during development of an Arthus reaction and that neutrophils undergoing phagocytosis of immune complexes may be the major source of PAF. The extent to which platelets or endothelial cells may contribute PAF is unclear.
Although there is convincing evidence that exogenous PAF can induce neutrophil-independent increases in vascular permeability (6) (7) (8) (9) (10) (11) and that PAF exhibits stimulatory properties with respect to neutrophils (13) (14) (15) (16) (17) (18) (19) , the relationship between neutrophils and endogenous PAF in the context of immune complex vasculitis has been unclear. Hellewell and Williams (12) have suggested that L-652,731 inhibits the Arthus reaction by blocking the effects of endogenous PAF. These investigators showed that L-652,731 does not inhibit kinin generation, C5a generation, lipoxygenase activity, or cyclooxygenase activity. Our observations that L-652,731 does not impede immune complex formation or scavenge HO lend further indirect support to this conclusion. The present study does not address the products that are derived from activated neutrophils and responsible for tissue injury. There is evidence suggesting roles for diverse neutrophil products, including proteases, oxidants, arachidonate metabolites, and cationic proteins/peptides in immune complex-induced tissue injury (1) (2) (3) (4) .
These data indicate that PAF participates in the pathogenesis of immune complex vasculitis through a neutrophil PAFreceptor mediated mechanism. In vitro data suggest that peripheral blood rat neutrophils may be directly activated or primed by picomolar to nanomolar concentrations of PAF to produce enhanced quantities of proinflammatory mediators. PAF appears to participate in the pathogenesis of immune complex vasculitis through both neutrophil-independent and neutrophil-dependent mechanisms.
